$DATS
DatChat, Inc. Stock $dats

$dats Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024042992 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$151.00	$131.00	$170.00
YoY Change	-12.21%	-14.94%	-95.66%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.041M	$1.430M	$1.098M
YoY Change	-47.66%	-32.45%	-53.01%
% of Gross Profit
Research & Development	$226.1K	$233.9K	$287.4K
YoY Change	-33.01%	-32.51%	12.25%
% of Gross Profit
Depreciation & Amortization	$5.790K	$5.782K	$8.250K
YoY Change	-19.13%	0.03%	-86.31%
% of Gross Profit
Operating Expenses	$1.267M	$1.664M	$1.385M
YoY Change	275.53%	380.0%	-46.56%
Operating Profit	-$1.267M	-$1.663M
YoY Change	-45.54%	-33.1%
Interest Expense	$63.00K	$101.5K	$138.7K
YoY Change	59.37%	-622.44%	119.19%
% of Operating Profit
Other Income/Expense, Net	$63.00K	$101.6K	-$63.80K
YoY Change	59.36%	16.66%
Pretax Income	-$1.204M	-$1.562M	-$1.354M
YoY Change	-47.36%	-34.9%	-61.69%
Income Tax
% Of Pretax Income
Net Earnings	-$983.2K	-$1.138M	-$1.354M
YoY Change	-57.01%	-52.58%	-61.69%
Net Earnings / Revenue	-651156.95%	-868558.78%	-796441.18%
Basic Earnings Per Share	-$0.33	-$0.56
Diluted Earnings Per Share	-$0.40	-$0.56	-$0.72
COMMON SHARES
Basic Shares Outstanding	3.009M shares	3.009M shares	2.103M shares
Diluted Shares Outstanding	3.009M shares	2.806M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.249M	$6.086M	$6.190M
YoY Change	-44.2%	-43.86%	-51.42%
Cash & Equivalents	$587.5K	$250.0K	$953.4K
Short-Term Investments	$4.661M	$5.836M	$5.237M
Other Short-Term Assets	$105.4K	$230.5K	$185.7K
YoY Change	-10.08%	-9.26%	37.8%
Inventory
Prepaid Expenses	$105.4K	$230.5K	$185.7K
Receivables	$192.00	$200.00	$180.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.355M	$6.317M	$6.376M
YoY Change	-43.78%	-43.07%	-50.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$45.00K	$50.78K	$130.5K
YoY Change	-54.52%	-31.29%	63.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$0.00
YoY Change			-100.0%
Total Long-Term Assets	$83.85K	$107.6K	$130.5K
YoY Change	-59.04%	-44.63%	-45.06%
TOTAL ASSETS
Total Short-Term Assets	$5.355M	$6.317M	$6.376M
Total Long-Term Assets	$83.85K	$107.6K	$130.5K
Total Assets	$5.438M	$6.425M	$6.507M
YoY Change	-44.1%	-43.1%	-50.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$361.4K	$384.5K	$322.8K
YoY Change	-15.63%	-14.67%	-20.23%
Accrued Expenses	$44.04K	$64.30K	$83.67K
YoY Change	-41.41%	-9.65%	24.25%
Deferred Revenue	$143.00	$162.00	$118.00
YoY Change	36.19%	20.0%	-36.56%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$405.5K	$448.9K	$406.6K
YoY Change	-19.47%	-13.98%	-14.13%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$405.5K	$448.9K	$406.6K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$405.5K	$448.9K	$406.6K
YoY Change	-25.95%	-23.41%	-27.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$50.26M	-$49.27M	-$48.13M
YoY Change	13.15%	16.96%	21.16%
Common Stock	$308.00	$308.00	$210.00
YoY Change	-85.15%	-85.15%	-89.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$398.0K	$398.0K	$398.0K
YoY Change	0.0%	27.89%
Treasury Stock Shares
Shareholders Equity	$6.120M	$6.842M	$6.100M
YoY Change
Total Liabilities & Shareholders Equity	$5.438M	$6.425M	$6.507M
YoY Change	-44.1%	-43.1%	-50.38%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$983.2K	-$1.138M	-$1.354M
YoY Change	-57.01%	-52.58%	-61.69%
Depreciation, Depletion And Amortization	$5.790K	$5.782K	$8.250K
YoY Change	-19.13%	0.03%	-86.31%
Cash From Operating Activities	-$1.073M	-$1.477M	-$1.370M
YoY Change	-24.46%	-16.05%	-10.54%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$1.176M	-$648.5K	$1.664M
YoY Change	-36.42%	-159.19%	-152.0%
Cash From Investing Activities	$1.176M	-$648.4K	$1.664M
YoY Change	-35.29%	-159.19%	-156.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	236.0K	$1.421M	0.000
YoY Change	-371.92%	-554.66%	-100.0%
NET CHANGE
Cash From Operating Activities	-1.073M	-$1.477M	-1.370M
Cash From Investing Activities	1.176M	-$648.4K	1.664M
Cash From Financing Activities	236.0K	$1.421M	0.000
Net Change In Cash	339.1K	-$704.9K	294.3K
YoY Change	9.22%	-27.82%	-106.54%
FREE CASH FLOW
Cash From Operating Activities	-$1.073M	-$1.477M	-$1.370M
Capital Expenditures			$0.00
Free Cash Flow			-$1.370M
YoY Change			5.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.16
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2806185	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2060721	shares
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40729
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	DATCHAT, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2502264
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	204 Neilson Street
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New Brunswick
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08901
CY2024Q1	dei	City Area Code CityAreaCode	(732)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	374-3529
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3009329	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	249983	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	953362	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	5836175	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	5236781	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	200	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	183	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	230530	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	185675	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6316888	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6376001	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50783	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	56565	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56854	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73977	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	107637	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	130542	usd
CY2024Q1	us-gaap	Assets Assets	6424525	usd
CY2023Q4	us-gaap	Assets Assets	6506543	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	384449	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	322762	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64298	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83674	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	162	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	118	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	448909	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	406554	usd
CY2024Q1	us-gaap	Liabilities Liabilities	448909	usd
CY2023Q4	us-gaap	Liabilities Liabilities	406554	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3076274	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2103321	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3009329	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2036376	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	308	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	210	usd
CY2024Q1	dats	Common Stock To Be Issued CommonStockToBeIssued	139	shares
CY2023Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	139	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56511333	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54597083	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	66945	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	66945	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	397969	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	397969	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	34553	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49271900	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48134088	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6841972	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6099989	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-866356	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5975616	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6099989	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6424525	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6506543	usd
CY2024Q1	us-gaap	Revenues Revenues	131	usd
CY2023Q1	us-gaap	Revenues Revenues	154	usd
CY2024Q1	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	897664	usd
CY2023Q1	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	1549692	usd
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	34717	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	113803	usd
CY2024Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	253625	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	255920	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233918	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	282773	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	243626	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	197102	usd
CY2023Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	23381	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1663550	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2422671	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1663419	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2422517	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	114470	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	28238	usd
CY2023Q1	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	42737	usd
CY2024Q1	dats	Gain On Deconsolidation Of Variable Interest Entities GainOnDeconsolidationOfVariableInterestEntities	107	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-12965	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-47672	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	101612	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	23303	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1561807	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2399214	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-423995	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1137812	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2399214	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1561807	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2399214	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	85035	usd
CY2024Q1	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	12965	usd
CY2023Q1	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	176	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1548842	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2314003	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.16
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2806185	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2060721	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6099989	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6695	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	22019	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	22500	usd
CY2024Q1	us-gaap	Partners Capital Account Public Sale Of Units Net Of Offering Costs PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts	149248	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	559251	usd
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	229919	usd
CY2024Q1	dats	Stock Issued During Period Value Sale Of Prefunded Warrants Net Of Allocated Offering Costs StockIssuedDuringPeriodValueSaleOfPrefundedWarrantsNetOfAllocatedOfferingCosts	861522	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34553	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1561807	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5975616	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	12556576	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	603278	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	21900	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	311174	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	132883	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2399214	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10704249	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1561807	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2399214	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5782	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5782	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	17123	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	14036	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6695	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	603278	usd
CY2024Q1	dats	Stockbased Professional Fees StockbasedProfessionalFees	47019	usd
CY2023Q1	dats	Stockbased Professional Fees StockbasedProfessionalFees	35878	usd
CY2024Q1	dats	Stockbased Professional Fees Dragon Interactive StockbasedProfessionalFeesDragonInteractive	5304	usd
CY2023Q1	dats	Gain From Initial Consolidation Of Variable Interest Entities GainFromInitialConsolidationOfVariableInterestEntities	42737	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	107	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-12965	usd
CY2023Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	23381	usd
CY2023Q1	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	22877	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-47672	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	52659	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33271	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	61794	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	45948	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-21801	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	44	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-51	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-19376	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15548	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1477240	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1759562	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2688668	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1995000	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3337115	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	964072	usd
CY2023Q1	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities	64538	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-648447	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1095466	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1315	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	559251	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	861522	usd
CY2023Q1	dats	Paymentsto Treasury Stock PaymentstoTreasuryStock	311174	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1420773	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-312489	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-704914	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-976585	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1535	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	176	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	953362	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1732956	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	249983	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	756547	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	442361	usd
CY2023Q1	dats	Increase In Shortterm Investments And Accumulated Other Comprehensive Gain IncreaseInShorttermInvestmentsAndAccumulatedOtherComprehensiveGain	100000	usd
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	800	usd
CY2023Q1	dats	Percentage Of Share Issued And Outstanding PercentageOfShareIssuedAndOutstanding	0.40	pure
CY2023Q4	dats	Additonal Common Stock AdditonalCommonStock	12000000	shares
CY2023Q4	us-gaap	Other General Expense OtherGeneralExpense	500000	usd
CY2022Q2	dats	Number Of Acquisition Share NumberOfAcquisitionShare	100000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	386480	usd
CY2024Q1	us-gaap	Other Minority Interests OtherMinorityInterests	55881	usd
CY2024Q1	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	107	usd
CY2023Q1	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	42737	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1561807	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	1477240	usd
CY2024Q1	dats	Accumulated Deficit For The Period AccumulatedDeficitForThePeriod	49271900	usd
CY2024Q1	us-gaap	Capital Capital	5867979	usd
CY2024Q1	us-gaap	Investments And Cash InvestmentsAndCash	249983	usd
CY2024Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	5836175	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Use of estimates</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates include assumptions used in assessing impairment of long-term assets, the valuation of intangible assets, the valuation of digital currencies and other digital assets, the valuation of lease liabilities and related right of use assets, the valuation of short-term investments, the valuation of deferred tax assets, the fair value of assets and liabilities of VIE’s on the initial VIE consolidation date, and the fair value of non-cash equity transactions.</p>
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	85035	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	200	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	183	usd
CY2024Q1	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	0	usd
CY2023Q1	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	23381	usd
CY2024Q1	us-gaap	Revenues Revenues	131	usd
CY2023Q1	us-gaap	Revenues Revenues	154	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233918	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	282773	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	113803	usd
CY2024Q1	dats	Largest Amount Of Tax Benefit LargestAmountOfTaxBenefit	0.50	pure
CY2024Q1	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	1535	usd
CY2023Q1	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	176	usd
CY2024Q1	dats	Common Stock Warrants CommonStockWarrants	67385	shares
CY2023Q1	dats	Common Stock Warrants CommonStockWarrants	67385	shares
CY2024Q1	dats	Common Stock Options CommonStockOptions	141170	shares
CY2023Q1	dats	Common Stock Options CommonStockOptions	171545	shares
CY2024Q1	dats	Commonstockequivalents Commonstockequivalents	208555	shares
CY2023Q1	dats	Commonstockequivalents Commonstockequivalents	238930	shares
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	22877	usd
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	63801	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	5836175	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	5836175	usd
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	5189263	usd
CY2023	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	47518	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	5236781	usd
CY2019Q1	dats	Operating Lease Monthly Base Rent OperatingLeaseMonthlyBaseRent	2567	usd
CY2022Q4	dats	Operating Lease New Monthly Base Rent OperatingLeaseNewMonthlyBaseRent	7156	usd
CY2024Q1	dats	Annual Increase Percentage In Lease Agreement AnnualIncreasePercentageInLeaseAgreement	0.03	pure
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	22738	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	22738	usd
CY2024Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P9M
CY2024Q1	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.18	pure
CY2024Q1	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2023Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2024Q1	dats	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	142044	usd
CY2023Q4	dats	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	124921	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56854	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73977	usd
CY2024Q1	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2023Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2024Q1	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-134600	usd
CY2023Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-115224	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	64298	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	83674	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64298	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	83674	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	69247	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	69247	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4949	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	64298	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	1315	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185600	usd
CY2024Q1	us-gaap	Other Income OtherIncome	18000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	18000	usd
CY2024Q1	us-gaap	Investments And Cash InvestmentsAndCash	120000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	200000	shares
CY2024Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	In August 2016, the Company designated one share of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which has a stated value equal to $1.00 as may be adjusted for any stock dividends, combinations or splits. Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote divided by (y) forty-nine one hundredths (0.49) minus (z) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote.
CY2023	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	10
CY2023Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	10	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.8499
CY2024Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1799939	usd
CY2024Q1	dats	Received Net Proceeds ReceivedNetProceeds	1420773	usd
CY2024Q1	dats	Underwriters Discounts And Offering Costs UnderwritersDiscountsAndOfferingCosts	279166	usd
CY2024Q1	us-gaap	Legal Fees LegalFees	100000	usd
CY2024Q1	dats	Underwriting Shares UnderwritingShares	590000	shares
CY2023Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	66945	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	47985	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	6.48
CY2023Q1	dats	Restricted Common Shares Issued RestrictedCommonSharesIssued	14300	shares
CY2023Q1	dats	Common Share Fair Values CommonShareFairValues	100000	usd
CY2023Q1	dats	Common Share Fair Value CommonShareFairValue	6.99
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	25000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	31720	usd
CY2024Q1	dats	Stock Options At Fair Value StockOptionsAtFairValue	22500	usd
CY2024Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.015
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5304	usd
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	17196	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	21500	shares
CY2023Q1	dats	Stock Option Exercisable Term StockOptionExercisableTerm	P5Y
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	12.5
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10000	shares
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	15
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	185628	usd
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.76
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	17500	shares
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	27031	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	178750	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	132366	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	20701	usd
CY2024Q1	dats	Share Based Compensation Related Expense ShareBasedCompensationRelatedExpense	28714	usd
CY2024Q1	dats	Stock Based Consulting Fees StockBasedConsultingFees	22019	usd
CY2023Q1	dats	Share Based Compensation Related Expense ShareBasedCompensationRelatedExpense	625178	usd
CY2023Q1	dats	Stock Based Consulting Fees StockBasedConsultingFees	21900	usd
CY2024Q1	dats	Stock Issued During Period Shares Issued For Service StockIssuedDuringPeriodSharesIssuedForService	38861	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P0Y7M6D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.68	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0396	pure
CY2024Q1	dats	Class Of Warrant Purchase Amount ClassOfWarrantPurchaseAmount	590000	shares
CY2024Q1	dats	Public Offering Price PublicOfferingPrice	1.8499
CY2024Q1	dats	Warrant Underwriters Excercise WarrantUnderwritersExcercise	590000	shares
CY2023Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2021Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	450000	usd
CY2021Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	350000	usd
CY2024Q1	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	300000	usd
CY2023Q1	us-gaap	Compensating Balance Amount CompensatingBalanceAmount	300000	usd
CY2024Q1	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	5000000	usd
CY2024Q1	dats	Placement Fee Percentage PlacementFeePercentage	0.10	pure
CY2024Q1	dats	Underwriting Discount Percentage UnderwritingDiscountPercentage	0.08	pure
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	25000	usd
CY2024Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	25000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss		usd
CY2023Q1	dats	Gain On Deconsolidation Of Variable Interest Entities GainOnDeconsolidationOfVariableInterestEntities		usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q1	dats	Stock Issued During Period Value Initial Recording On Noncontrolling Interest StockIssuedDuringPeriodValueInitialRecordingOnNoncontrollingInterest		usd
CY2023Q1	dats	Common Stocks Amount Rounding CommonStocksAmountRounding		usd
CY2024Q1	dats	Gain From Initial Consolidation Of Variable Interest Entities GainFromInitialConsolidationOfVariableInterestEntities		usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2024Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2024Q1	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments		usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties		usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2024Q1	dats	Paymentsto Treasury Stock PaymentstoTreasuryStock		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2024Q1	dats	Increase In Shortterm Investments And Accumulated Other Comprehensive Gain IncreaseInShorttermInvestmentsAndAccumulatedOtherComprehensiveGain		usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	34717	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2024Q1	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments		usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001648960

Files In Submission

Name	View Source	Status
0001213900-24-042992-index-headers.html	Edgar Link	pending
0001213900-24-042992-index.html	Edgar Link	pending
0001213900-24-042992.txt	Edgar Link	pending
0001213900-24-042992-xbrl.zip	Edgar Link	pending
dats-20240331.xsd	Edgar Link	pending
ea0205850-10q_datchat.htm	Edgar Link	pending
ea020585001ex31-1_datchat.htm	Edgar Link	pending
ea020585001ex31-2_datchat.htm	Edgar Link	pending
ea020585001ex32-1_datchat.htm	Edgar Link	pending
ea020585001ex32-2_datchat.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
dats-20240331_def.xml	Edgar Link	unprocessable
dats-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0205850-10q_datchat_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dats-20240331_cal.xml	Edgar Link	unprocessable
dats-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DATS
DatChat, Inc. Stock $dats

2024 Q2 Form 10-Q Financial Statement

#000121390024042992 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS DatChat, Inc. Stock $dats

2024 Q2 Form 10-Q Financial Statement

#000121390024042992 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS
DatChat, Inc. Stock $dats